ArticleThe Journal of clinical investigation2026

Epigenetic and oncogenic inhibitors converge to drive a metabolic catastrophe in castration-resistant prostate cancer.

Rhea Sahu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.